Pharmaceuticals, among other products, will not be subject to the reciprocal tariffs, according to a White House fact sheet ...

Pharma stocks plummet as Trump threatens tariffs, impacting US-dependent companies and leading to market volatility.

As per Geojit Investments report, Zydus Lifesciences' 47 percentage of revenue comes from the US. Similarly, Aurobindo Pharma ...

Given Zydus Lifesciences and Dr Reddy’s Laboratories have high US sales exposure with ~45% and 43% sales contribution, ...

US-India pharmaceutical and medical device industries navigate Trump's tariff plan, with potential impacts on exports and ...

New Delhi: Zydus Lifesciences has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

Jefferies pointed out that India currently imposes up to 10% import duties on US drugs, with some having lower duties or ...

Granules India, Lupin, Gland Pharma and Cipla fell 5-6 per cent. Sun Pharmaceutical Industries slipped 5 per cent while Dr ...

Zydus Family Trust purchased a luxury apartment in Mumbai's Oberoi Realty project for ₹200 crore. Covering 17,384 sq ft, the ...

Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices ...

Large Indian drug manufacturers experienced relief as President Trump's administration decided against imposing expected ...

Trump had earlier said on March 24 that he will announce tariffs on automobiles, pharmaceuticals and aluminum in the near ...